AdisInsight: Drugs

AdisInsight: Drugs (formerly Adis R&D Insight) provides leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are tracked across all therapeutic areas and throughout the entire development process, from discovery to launch.

AdisInsight drug profiles include:

 Key development milestones
 Development status and history
 Drug properties
 Chemical synopses
 Pharmacokinetics data
 Pharmacodynamics data
 Company agreements
 Trial landscape and details
 Related safety reports
 Patent information
 Related drugs
 Drug limitations
 Immunogenicity

Data is collected from more than 2,300 biomedical journals covering drugs and therapeutics, news services, newsletters, company annual reports, contact with companies, market intelligence, meetings and conferences.

Information reported in AdisInsight: Drugs includes:

 Generic name, synonyms, brand names
 Developing companies
 Development phases by indication and country
 Adverse events, pharmacology, pharmacokinetics, pharmacodynamics, therapeutic trials
 Development history
 Forecasts of approval probability, and revenue

AdisInsight profiles are also backed by more than 10,000 evaluated Adis scientific summaries and 63,000 bibliographic references.

Find out more